- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-26-0495822

Ukin Pharma Private Limited
About Ukin Pharma Private Limited
Data last updated:
Ukin Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It was incorporated on 25 April 2023.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U47721PN2023PTC219927.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sonam Kumari and Sadhana Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.19 Lakh, a growth of 116% compared to the previous year. For the same year it recorded a net loss of ₹23,200 (net margin -1.9%) and EBITDA of -₹23,200 (EBITDA margin -1.9%).
Ukin Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0495822).
Recognitions & Rankings of Ukin Pharma
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFl No – 503 Pl No – 44, S No – 45/1 Harihareshwar Ambar Haveli, Pune, Maharashtra, India – 411041
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ukin Pharma Private Limited
The main business activity of Ukin Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ukin Pharma Private Limited FY 2025 filings available
Ukin Pharma Private Limited reported revenue of ₹12.19 Lakh (up 116% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ukin Pharma Private Limited
Revenue rose 116% in the latest year. EBITDA fell 246% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Ukin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹23,200 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹23,200 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Ukin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -1.9% | •••• |
| Net Profit Margin | -1.9% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ukin Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ukin Pharma Private Limited
Ukin Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonam Kumari | Director | 25 Apr 2023 | 3 Years 5 Months | Current |
| Sadhana Singh | Director | 25 Apr 2023 | 3 Years 5 Months | Current |
Peer Comparison of Ukin Pharma Private Limited
Ukin Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Endolax Medicare Private Limited | ₹12.51 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Rashika Medicare Private Limited | ₹12.39 Lakh (FY 2025) | •••• | •••• | 106.0% | •••• | Gurgaon, Haryana, India |
| Safewin Pharma Private Limited | ₹12.25 Lakh (FY 2025) | •••• | •••• | 553.0% | •••• | Agra, Uttar Pradesh, India |
| Celesta Healthcare Private Limited | ₹12.24 Lakh (FY 2025) | •••• | •••• | •••• | Roorkee, Uttarakhand, India | |
| RX Nutra India Private Limited | ₹12.23 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Ukin Pharma Private Limited this company | ₹12.19 Lakh (FY 2025) | •••• | •••• | 116.0% | •••• | Pune, Maharashtra, India |
| Deepjyoti Fine Chemicals Private Limited | ₹12.15 Lakh (FY 2022) | •••• | •••• | -49.0% | •••• | Boisar, Maharashtra, India |
| Jagaddhatri Data Analytics and Engineering Private Limited | ₹12.04 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Kolkata, West Bengal, India |
| Diabello Healthcare Private Limited | ₹12.02 Lakh (FY 2024) | •••• | •••• | •••• | Nashik, Maharashtra, India | |
| Canary Biosensors Private Limited | ₹11.81 Lakh (FY 2024) | •••• | •••• | •••• | Sriperumbudur, Tamil Nadu, India | |
| Tnine Pharmaceuticals Private Limited | ₹11.78 Lakh (FY 2025) | •••• | •••• | 2617.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ukin Pharma by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Ukin Pharma Private Limited
Ukin Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ukin Pharma Private Limited
Employment history and EPFO contributions of people linked to Ukin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ukin Pharma Private Limited
Ukin Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Sadhana Singh was appointed as Director on 25 Apr 2023.
Credit Ratings, Litigation & Regulatory Alerts for Ukin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ukin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ukin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ukin Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ukin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ukin Pharma Private Limited
Ukin Pharma is an active private limited company based in Pune, Maharashtra, India. It was incorporated on 25 April 2023 (3+ years old) and is registered under CIN U47721PN2023PTC219927.
Ukin Pharma reported revenue of ₹12.19 Lakh for FY 2025 (up 116% YoY).
Ukin Pharma has 2 current directors:
- Sonam Kumari - Director
- Sadhana Singh - Director
Ukin Pharma reported a net loss of ₹23,200 (net margin -1.9%) and EBITDA of -₹23,200 (EBITDA margin -1.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Ukin Pharma is U47721PN2023PTC219927. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ukin Pharma was incorporated on 25 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Ukin Pharma by revenue are Endolax Medicare Private Limited, Rashika Medicare Private Limited, Safewin Pharma Private Limited, Celesta Healthcare Private Limited, RX Nutra India Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Sadhana Singh was appointed as Director on 25 Apr 2023. Sonam Kumari was appointed as Director on 25 Apr 2023.
Yes, Ukin Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0495822).
The registered office of Ukin Pharma is at Fl No – 503 Pl No – 44, S No – 451 Harihareshwar Ambar Haveli, Pune, Maharashtra, India – 411041.
Ukin Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.